← All trials
NCT01671982
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2012
- Primary completion
- Jan 31, 2014
- Completion date
- May 31, 2015
- First posted
- Aug 24, 2012
- Last posted
- Oct 31, 2023
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of FranceLead sponsor
- Chiangmai UniversityCollaborator
- Government of FranceReponsible party - principal investigator
- The Government Pharmaceutical OrganizationCollaborator
- Chiangmai UniversityOfficial
- Government of FranceSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.